GlassScriptPhysician profile
Jie Xu
NPI 1588895767
$1,875.17
in general payments reported to CMS, 2019-2025
33 companies · $638 in 2025
The $638 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $155 · 2021: $49.00 · 2022: $81.47 · 2023: $254 · 2024: $263 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $270.29 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $238.33 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $146.78 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $127.31 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $103.84 | 2019-2023 | Injectafer |
| Coopersurgical, INC. | $81.70 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $70.60 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $60.82 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $58.09 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $55.49 | 2023-2025 | |
| Mylan Pharmaceuticals INC. | $50.62 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.33 | 2019-2023 | |
| Shield Therapeutics INC | $46.80 | 2024 | |
| Baxter Healthcare | $40.73 | 2024 | Tisseel |
| Therapeuticsmd, INC. | $40.68 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $39.33 | 2022-2025 | Closurefast |
| Duchesnay USA Incorporated | $36.21 | 2019 | |
| Allergan, INC. | $35.61 | 2019 | |
| Hologic Sales and Service, LLC | $35.60 | 2022-2024 | Aptima |
| Amgen INC. | $34.78 | 2019 | |
| Millicent US INC | $34.13 | 2025 | Femlyv, Intrarosa |
| Smith+Nephew, INC. | $27.78 | 2019-2023 | Stravix, Grafix Pl, Stravix Pl |
| Supernus Pharmaceuticals, INC. | $23.74 | 2025 | Qelbree |
| Gynesonics, INC. | $21.71 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Roche Diagnostics Corporation | $21.21 | 2019 | |
| Exeltis, USA INC. | $19.40 | 2023 | Slynd |
| Aspira Women'S Health INC | $18.03 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $17.63 | 2025 | |
| Kci USA, INC. | $15.60 | 2020 | |
| Avion Pharmaceuticals | $14.90 | 2020 | |
| Dysis Medical, INC. | $13.61 | 2019 | |
| Convatec INC. | $13.54 | 2021 | |
| Meditrina | $9.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jie Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.